Related Experiment Video
Updated: Apr 5, 2026

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
Published on: May 12, 2023
Single-injection vaccines: Progress, challenges, and opportunities
Kevin J McHugh1, Rohiverth Guarecuco1, Robert Langer1
1David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, United States.
Insights
Single-administration vaccines aim to improve global immunization by releasing antigens over time. Challenges like antigen stability and release kinetics hinder their development, but strategies are being explored.
Area of Science:
- Immunology
- Biotechnology
- Vaccine Development
Background:
- Current multi-dose vaccination schedules leave millions of infants underimmunized annually.
- Logistical barriers, especially in developing nations, limit access to timely immunization.
- Single-administration vaccines offer a potential solution by providing sustained antigen release.
Purpose of the Study:
- To review the current status of single-administration vaccine technology.
- To identify key challenges impeding the commercialization of these vaccines.
- To discuss potential strategies for overcoming developmental hurdles.
Main Methods:
- Review of existing literature on controlled-release antigen delivery systems.
- Analysis of challenges related to antigen stability and release kinetics.
- Exploration of strategies to achieve desired release profiles and enhance antigen stability.
Main Results:
- Controlled-release systems for single-administration vaccines have been researched for decades.
- Commercialization is hindered by poor antigen stability and difficulties in achieving specific release kinetics.
- Various strategies are being investigated to address these limitations.
Conclusions:
- Single-administration vaccines hold significant promise for improving global immunization coverage.
- Overcoming challenges in antigen stability and controlled release is crucial for clinical translation.
- Continued research into novel delivery systems and formulation strategies is essential.
Abstract:
Currently, vaccination is the most efficient and cost-effective medical treatment for infectious diseases; however, each year 10 million infants remain underimmunized due to current vaccination schedules that require multiple doses to be administered across months or years. These dosing regimens are especially challenging in the developing world where limited healthcare access poses a major logistical barrier to immunization. Over the past four decades, researchers have attempted to overcome this issue by developing single-administration vaccines based on controlled-release antigen delivery systems. These systems can be administered once, but release antigen over an extended period of time to elicit both primary and secondary immune responses resulting in antigen-specific immunological memory. Unfortunately, unlike controlled release systems for drugs, single-administration vaccines have yet to be commercialized due to poor antigen stability and difficulty in obtaining unconventional release kinetics. This review discusses the current state of single-administration vaccination, challenges delaying the development of these vaccines, and potential strategies for overcoming these challenges.
Related Concept Videos
Vaccine Production
Microorganisms in Medicine and Therapeutics
Vaccinations
Vaccines
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

